![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
ASCO Publications
Feb 5, 2014 · Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and …
Outpatient Management of Fever and Neutropenia in Adults …
Feb 20, 2018 · Neutropenia, a decrease in the absolute neutrophil count (ANC), occurs frequently in recipients of chemotherapy. 1 Neutrophils are critical in providing host defense against …
Evidence-Based Management of Oral Mucositis | JCO Oncology …
Feb 3, 2020 · As well described in the clinical review by Brown and Gupta 1 in this issue of JCO Oncology Practice, oral mucositis is a common toxicity of cancer therapy.The morbidity of oral …
Breast Cancer Brain Metastasis: A Comprehensive Review
May 15, 2024 · Brain metastases (BMs) occur in 20%-40% of patients with breast cancer during the course of their disease. 1 BMs from solid tumors contribute significantly to morbidity and/or …
Survival in Patients With Brain Metastases: Summary Report on the ...
Sep 15, 2020 · Significant prognostic factors varied by diagnosis and new prognostic factors were identified. Those factors were incorporated into the updated GPA with robust separation (P < …
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
In the United States, the Controlled Substance Act renders cannabis with >0.3% delta-9-tetrahydrocannabinol (THC) schedule I. This status signifies that cannabis has no accepted …
Systemic Treatment of Patients With Metastatic Breast Cancer: …
Jan 10, 2024 · Clinicians should recommend treatment according to menopausal status, pathological and biomarker features when quality results are available. In first-line, for …
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
In the United States, it is estimated that between 8% and 10% of patients with cancer will develop brain metastases representing approximately 200,000 new patients with brain metastases …
Management of Immune-Related Adverse Events in Patients …
Immunotherapy has revolutionized the treatment of many different types of cancers. Immune checkpoint inhibitors (ICPis) targeting cytotoxic T-lymphocyte–associated antigen-4 (CTLA-4), …
Palliative Care for Patients With Cancer: ASCO Guideline Update
May 15, 2024 · Evidence-based recommendations address the integration of palliative care in oncology. Oncology clinicians should refer patients with advanced solid tumors and …